Melanoma Diagnostics Inc., Myriad Genetics deal

Myriad Genetics received exclusive, worldwide rights to Melanoma Diagnostics' technology to develop and commercialize tests to detect malignant melanoma. Myriad expects to launch a melanoma diagnostic...